Canadian Reimbursement

Cornerstone’s extensive Canadian experience has provided numerous opportunities to positively impact patient access to a wide range of therapies through public and private plans. We have a track record of successful CDR, and pCODR and provincial plan reimbursement submissions – 85%!

  • Strategic support for market access and pricing
  • CDR, pCODR, provincial reimbursement submissions
  • Reimbursement insights through
  • Cost-effectiveness analyses and budget impact analyses
  • Payer advisory boards and mock CDR panels
  • Clinical summaries

“Cornerstone submissions are among the best I have reviewed” -CDR Reviewer

Comments are closed.

Copyright © 2020. All Rights Reserved. Cornerstone Research Group